Deep Track Capital, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Deep Track Capital, LP disclosed 61 US equity positions worth $2.7bn in its Q4 2024 13F filing. The largest position was DVAX at 8.5% of the reported book, followed by GH and ITCIEUR. Against the Q3 2024 filing, it opened 12 new positions, added to 15 and reduced 14 among the top 50 holdings.
What did Deep Track Capital, LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | DVAX DYNAVAX TECHNOLOGIES CORP | 8.5% | $227.2m | 17,791,486 | 42% | added | |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 7.4% | $196.1m | 6,419,566 | 7% | added |
| 3 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 6.3% | $167.0m | 2,000,000 | 25% | added | |
| 4 | IMVT IMMUNOVANT INC | Healthcare | 5.6% | $148.6m | 6,000,000 | 38% | added |
| 5 | APLSUSD APELLIS PHARMACEUTICALS INC | 5.1% | $136.4m | 4,274,921 | -3% | reduced | |
| 6 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 4.7% | $125.0m | 3,460,756 | -10% | reduced | |
| 7 | CYTK CYTOKINETICS INC | Healthcare | 4.4% | $117.6m | 2,500,000 | 297% | added |
| 8 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 4.1% | $109.6m | 12,836,282 | 1% | added |
| 9 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.3% | $86.7m | 4,522,741 | 21% | added |
| 10 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 2.9% | $78.7m | 5,972,257 | 0% | held |
| 11 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 2.8% | $75.9m | 2,800,000 | 129% | added |
| 12 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 2.5% | $67.6m | 1,933,928 | -12% | reduced |
| 13 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.1% | $56.5m | 3,000,000 | -22% | reduced |
| 14 | MBX MBX BIOSCIENCES INC | Healthcare | 2.1% | $55.6m | 3,018,935 | 0% | held |
| 15 | ETNBGBP 89BIO INC | 1.9% | $50.7m | 6,478,249 | 134% | added | |
| 16 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.9% | $49.9m | 1,450,000 | – | new |
| 17 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.8% | $47.1m | 2,000,000 | -39% | reduced |
| 18 | SEPN SEPTERNA INC | 1.6% | $43.8m | 1,912,929 | – | new | |
| 19 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 1.6% | $42.4m | 4,000,000 | 605% | added |
| 20 | GMAB GENMAB A/S | Healthcare | 1.6% | $41.7m | 2,000,000 | – | new |
| 21 | AKERO THERAPEUTICS INC | 1.6% | $41.5m | 1,490,000 | 116% | added | |
| 22 | VRNA VERONA PHARMA PLC | 1.5% | $39.5m | 850,000 | -73% | reduced | |
| 23 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.5% | $38.9m | 1,540,132 | – | new |
| 24 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.4% | $38.6m | 1,000,000 | – | new |
| 25 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.3% | $35.9m | 649,042 | 29% | added |
| 26 | BCAX BICARA THERAPEUTICS INC | 1.3% | $34.8m | 2,000,000 | 151% | added | |
| 27 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 1.3% | $33.4m | 14,218,903 | -7% | reduced |
| 28 | KRRO KORRO BIO INC | Healthcare | 1.2% | $33.3m | 874,614 | 3% | added |
| 29 | 430 TERNS PHARMACEUTICALS INC | 1.2% | $30.9m | 5,576,558 | 0% | held | |
| 30 | ENGENE HOLDINGS INC | 1.1% | $30.3m | 4,557,575 | 75% | added | |
| 31 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.0% | $27.5m | 653,513 | – | new |
| 32 | ABVX ABIVAX SA | 1.0% | $26.2m | 3,579,209 | 0% | held | |
| 33 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.8% | $22.6m | 1,350,000 | 0% | held | |
| 34 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.8% | $22.5m | 819,162 | – | new |
| 35 | LKFT GALAPAGOS NV | Healthcare | 0.8% | $21.5m | 780,778 | – | new |
| 36 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 0.8% | $20.1m | 3,442,833 | -14% | reduced |
| 37 | BRD1EUR MIND MEDICINE MINDMED INC | 0.7% | $19.6m | 2,816,594 | -60% | reduced | |
| 38 | EWTX EDGEWISE THERAPEUTICS INC | 0.7% | $19.0m | 710,421 | -35% | reduced | |
| 39 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.7% | $17.9m | 1,276,081 | -64% | reduced |
| 40 | UPB UPSTREAM BIO INC | 0.6% | $16.4m | 1,000,000 | – | new | |
| 41 | NVAX NOVAVAX INC | Healthcare | 0.6% | $16.1m | 2,000,000 | – | new |
| 42 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.6% | $15.3m | 519,376 | – | new |
| 43 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.5% | $14.5m | 750,000 | -39% | reduced |
| 44 | GERN GERON CORP | Healthcare | 0.5% | $14.2m | 4,011,287 | -47% | reduced |
| 45 | HELP CYBIN INC | 0.5% | $13.5m | 1,529,987 | 0% | held | |
| 46 | XNCR XENCOR INC | Healthcare | 0.4% | $11.5m | 500,000 | -38% | reduced |
| 47 | ALGS ALIGOS THERAPEUTICS INC | 0.4% | $9.7m | 244,110 | 0% | held | |
| 48 | RAPT THERAPEUTICS INC | 0.4% | $9.5m | 6,011,380 | – | new | |
| 49 | ZURA ZURA BIO LTD | Healthcare | 0.3% | $8.2m | 3,283,783 | 0% | held |
| 50 | CNTX CONTEXT THERAPEUTICS INC | 0.3% | $7.8m | 7,419,355 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.